[Radiotherapy of stage T1-T2 M0 prostatic adenocarcinoma. Analysis of the carcinologic results of a multicenter study of 610 patients. Groupe Radiothérapie de la Commission de Coopération Médicale Intercentres (CCMI)].
Rozan R, Albuisson E, Giraud B, Boiteux JP, Dauplat J, Donnarieix D, Alcaraz L, Auvray H, Allain YM, Duchatelard PP, Pigneux J, Richaud P, Bonichon F, Bachaud JM, Hay M, Chenal C, Julienne V, Brune D, Mace-Lesec'h JJ, Beckendorf V, Bey P, Eschwege F, Pontvert D, Bolla M, Rambert P, et al.
Rozan R, et al.
Cancer Radiother. 1998 Jul-Aug;2(4):338-50. doi: 10.1016/s1278-3218(98)80345-4.
Cancer Radiother. 1998.
PMID: 9755747
French.